International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress

DF Woodward, RL Jones, S Narumiya - Pharmacological reviews, 2011 - ASPET
It is now more than 15 years since the molecular structures of the major prostanoid receptors
were elucidated. Since then, substantial progress has been achieved with respect to …

Mucins, mucus, and sputum

JA Voynow, BK Rubin - Chest, 2009 - Elsevier
Normal airway mucus lines the epithelial surface and provides an important innate immune
function by detoxifying noxious molecules and by trapping and removing pathogens and …

Bronchial epithelial cells: the key effector cells in the pathogenesis of chronic obstructive pulmonary disease?

W Gao, L Li, Y Wang, S Zhang, IM Adcock… - …, 2015 - Wiley Online Library
The primary function of the bronchial epithelium is to act as a defensive barrier aiding the
maintenance of normal airway function. Bronchial epithelial cells (BEC) form the interface …

Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease

T Yoshida, RM Tuder - Physiological reviews, 2007 - journals.physiology.org
Chronic obstructive pulmonary diseases (COPD), comprised of pulmonary emphysema,
chronic bronchitis, and structural and inflammatory changes of small airways, is a leading …

CFTR, mucins, and mucus obstruction in cystic fibrosis

SM Kreda, CW Davis, MC Rose - Cold Spring …, 2012 - perspectivesinmedicine.cshlp.org
Mucus pathology in cystic fibrosis (CF) has been known for as long as the disease has been
recognized and is sometimes called mucoviscidosis. The disease is marked by mucus …

Roles of cyclic AMP response element binding activation in the ERK1/2 and p38 MAPK signalling pathway in central nervous system, cardiovascular system …

Y Koga, H Tsurumaki, H Aoki-Saito, M Sato… - International journal of …, 2019 - mdpi.com
There are many downstream targets of mitogen-activated protein kinase (MAPK) signalling
that are involved in neuronal development, cellular differentiation, cell migration, cancer …

The preclinical pharmacology of roflumilast–a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease

A Hatzelmann, EJ Morcillo, G Lungarella… - Pulmonary …, 2010 - Elsevier
After more than two decades of research into phosphodiesterase 4 (PDE4) inhibitors,
roflumilast (3-cyclopropylmethoxy-4-difluoromethoxy-N-[3, 5-di-chloropyrid-4-yl]-benzamide) …

Regulation of airway MUC5AC expression by IL-1β and IL-17A; the NF-κB paradigm

T Fujisawa, S Velichko, P Thai, LY Hung… - The Journal of …, 2009 - journals.aai.org
Mucin over-production is one of the hallmarks of chronic airway diseases such as chronic
obstructive pulmonary disease, asthma, and cystic fibrosis. NF-κB activation in airway …

Airway mucus: the good, the bad, the sticky

CM Evans, JS Koo - Pharmacology & therapeutics, 2009 - Elsevier
Mucus production is a primary defense mechanism for maintaining lung health. However,
the overproduction of mucin (the chief glycoprotein component of mucus) is a common …

Regulation of airway mucin gene expression

P Thai, A Loukoianov, S Wachi, R Wu - Annu. Rev. Physiol., 2008 - annualreviews.org
Mucins are important components that exert a variety of functions in cell-cell interaction,
epidermal growth factor receptor signaling, and airways protection. In the conducting …